Recent developments highlight the company’s active participation in defense industry events, product launches, leadership announcements, and strategic acquisitions, reflecting ongoing execution of its modular drone platform strategy and expansion into related markets.

• Citrine Global Corp. (DBA SkyTech Orion Global Corp.) announced CEO Ora Elharar Soffer as a keynote speaker at UVID 2025 and showcased the SkyTech Replicator™ modular drone platform and SkyTech Center, Israel’s UAV hub [N1].
• The company participated at AUVSI Defense 2025 in Washington, D.C., launching the SkyTech Replicator™, a revolutionary modular drone that transforms into four different mission drones [N2].
• A shareholder update letter was issued by the company’s Chairwoman and CEO, Ora Elharar-Soffer, in October 2025 [N3].
• In November 2023, the company announced a binding agreement to acquire 51% of iBOT Israel Botanicals, a revenue-generating nutritional supplements company with fast-growing potential [N4].
• The company filed provisional patent applications in 2022 targeting balancing side effects and oral cavity side effects associated with medicines and treatments [N5][N6].
• Prof. Itamar Grotto, a world-renowned public health expert, joined the company’s Israeli subsidiary board and was appointed president of Green Vision Center Israel in 2022 [N7].
• The company issued a letter to shareholders in April 2022 outlining strategic updates and operational progress [N8].

The company’s modular drone platform and scalable manufacturing approach align with increasing demand for small tactical drones in defense markets, particularly in the U.S. and allied countries. Its NDAA-compliant supply chain and government-backed infrastructure in Israel position it to capture opportunities arising from regulatory restrictions on foreign drone components. The SkyTech Replicator™ platform’s flexibility across multiple mission profiles and rapid reconfiguration capabilities may appeal to military and advanced civilian customers. Strategic acquisitions and patent filings support technology expansion and market reach. The company’s participation in key defense industry events and leadership visibility enhance its profile and potential partnerships.

The company operates with a significant working capital deficiency and limited cash resources, which may constrain operational flexibility. Geopolitical instability in Israel and ongoing regional conflicts pose risks to supply chains, operations, and business continuity. The defense drone market is competitive, with rapid technological advancements and evolving regulatory requirements that may challenge the company’s ability to maintain differentiation. The company’s financial losses and limited revenue disclosure indicate early-stage commercialization with execution risks. Regulatory approvals and certification processes remain ongoing, potentially delaying market entry and scaling. Dependence on government grants and incentives introduces uncertainty in long-term funding.

The company’s competitive differentiation lies in its proprietary modular drone platform architecture, which enables rapid reconfiguration and scalability across multiple mission profiles within a unified system. Its Replication Manufacturing Method™ supports efficient, standardized, and distributed production cells, facilitating large-scale manufacturing capacity. The company’s focus on NDAA-compliant, Western-aligned supply chains addresses regulatory constraints in the defense drone market, creating barriers for competitors reliant on restricted components. The government-backed SkyTech Center Israel provides strategic infrastructure, grants, and regulatory support, enhancing the company’s position as a national hub for drone innovation and production. The company’s intellectual property portfolio, including multiple patent applications covering modular unmanned systems and unified interface technologies, further protects its technological foundation. These factors collectively contribute to a defensible position in the emerging modular small drone market for defense and dual-use applications.

• Geopolitical and Regional Risks: The company’s significant operations and subsidiaries are based in Israel, exposing it to geopolitical instability and military conflicts, including the ongoing war since October 2023, which may disrupt supply chains, operations, and access to resources.
• Financial and Liquidity Risks: The company reported a working capital deficiency and net losses, with limited cash and current assets relative to liabilities, which may impact its ability to fund operations and scale production without additional financing.
• Regulatory and Compliance Risks: The company is advancing regulatory and certification processes for its drone products and manufacturing facilities. Delays or failures in obtaining necessary approvals could hinder market access and growth.
• Market and Competitive Risks: The small drone market is competitive with rapid technological changes. The company faces risks in maintaining technological differentiation, meeting evolving customer requirements, and competing against established and emerging players.

• Citrine Global, Corp. renamed to SkyTech Orion Global Corp. in October 2025 and operates as a U.S.-based corporation with subsidiaries in Israel, including CTGL-Citrine Global Israel Ltd. and majority-owned SkyTech Orion Ltd.
• The company focuses on building end-to-end drone solutions, emphasizing innovative modular drone platforms and large-scale production capabilities.
• Its core technology is a proprietary modular architecture separating intelligent core systems from airframe, power, sensors, communications, and payload components, enabling flexibility and scalability.
• The flagship product is the SkyTech Replicator™ Modular Drone Platform, designed for multiple configurations and mission profiles within a unified system.
• The company targets the defense and dual-use markets with NDAA-compliant, Western-aligned supply chains to ensure security and regulatory compliance.
• SkyTech Replicator™ supports missions including intelligence, surveillance, reconnaissance (ISR), tactical operations, loitering/attack drones, logistics, and real-time battlefield support.
• The company has developed the Replication Manufacturing Method™ to enable scalable, distributed, and standardized production cells, including advanced manufacturing technologies like 3D printing.
• SkyTech Center Israel is a government-backed national project located in Yerucham, Israel, serving as a hub for UAV and drone manufacturing, R&D, testing, regulatory compliance, and business development.
• The company has received government grants and benefits for the SkyTech Center Israel project, including tax incentives and employment support.
• The company has filed multiple patent applications covering its modular unmanned systems technology, including cross-domain modular platforms and unified interface systems.
• Financial figures as of December 31, 2025, include a net loss of approximately $1.917 million, cash and cash equivalents of $10,000, current assets of $166,000, and current liabilities of $4.757 million, resulting in a working capital deficiency.
• The company incurred increased research and development expenses in 2025 related to defense sector activities starting in Q3 2025.
• Marketing, general and administrative expenses decreased in 2025 compared to 2024, primarily due to lower professional services and share-based compensation.
• The company operates with a working capital deficiency and has a cash ratio of 0.01 and a current ratio of 0.03 as of December 31, 2025.
• The company is exposed to geopolitical risks due to its Israeli operations, including the ongoing conflict in the region since October 2023.
• Recent news highlights include the CEO Ora Elharar Soffer announced as a keynote speaker at UVID 2025 and showcasing the SkyTech Replicator™ platform and SkyTech Center [N1].
• The company participated at AUVSI Defense 2025 in Washington, D.C., launching the SkyTech Replicator™, a modular drone transforming into four different mission drones [N2].
• A shareholder update letter was issued by the Chairwoman and CEO Ora Elharar-Soffer in October 2025 [N3].
• In November 2023, the company announced a binding agreement to acquire 51% of iBOT Israel Botanicals, a revenue-generating nutritional supplements company [N4].
• The company filed provisional patent applications in 2022 and 2021 related to balancing side effects and pharmaceutical compositions for treatment of side effects associated with cannabis and related products [N5][N6].
• Prof. Itamar Grotto, a public health expert, joined the company’s Israeli subsidiary board and was appointed president of Green Vision Center Israel in 2022 [N7].
• The company has a history of strategic acquisitions, patent filings, and government-supported infrastructure development in Israel.
• The company’s business strategy combines U.S. and Israeli R&D and manufacturing to provide secure, scalable drone platforms for defense and allied markets [S1].